corneal collagen crosslinking

Epi-on CXL: Safe, effective option for treating thin corneasPatients with thin corneas as the result of keratoconus, ectasia following LASIK, or pellucid marginal degeneration can safely undergo epithelial-on collagen crosslinking with pulsed UV light and achieve visual benefits from the procedure.
Study: Not all topography devices are alikeSubclinical haze after CXL can affect corneal topography measurements; a comparison shows that measurements with four different devices cannot be used interchangeably.
4 reasons to use a compounding pharmacyThere are four reasons to opt for a compounding pharmacy instead of reach for your Rx pad: strength, form, ingredients, and function.
Surgical pearls for CXL treatment of keratoconus, corneal ectasia
Surgical pearls for CXL treatment of keratoconus, corneal ectasiaOn the heels of the recent FDA approval of corneal collagen crosslinking, some surgical pearls are provided for the treatment of progressive keratoconus and corneal ectasia.
Binkhorst Lecture: Predicting, treating keratoconus in 2016The Binkhorst Lecture and Medal have been conferred since 1975 on “an individual whose career has made significant contributions to the science and practice of ophthalmology and established that person among the world’s most prominent ophthalmologists.”
A closer look at riboflavin application for corneal collagen crosslinkingCorneal collagen crosslinking with riboflavin works well but requires further exploration to identify the best approach for various types of patients.
How corneal biomechanics affects keratoconus and ectasiaIn a landmark paper titled “Global consensus on keratoconus and ectatic diseases” published in the April 2015 issue of Cornea, Gomes et al sought to reach a consensus of the definition, concepts, clinical management, and surgical treatments of keratoconus and the family of corneal ectatic diseases.
New treatment options revise the prognosis for keratoconusUnderstanding of keratoconus and the resulting dramatic changes in management in recent years have given rise to treatment paradigms that would have been unrecognizable to ophthalmologists a generation ago. The new landscape features a wider range of treatment options, better diagnostic and monitoring tools, and better understanding of the underlying pathology of the disease.
Managing progressive keratoconus with the triple procedureFindings from a study undertaken at Dr Lovisolo’s practice indicate that in carefully-selected patients, a triple procedure, comprising Keraring implantation followed by accelerated CXL and topo-guided ablation can provide significant functional improvement in cases of progressive keratoconus.
Riboflavin delivery methods advance as techniques evolveTechniques for performing corneal collagen crosslink (CXL) are being evaluated and adapted, and at the same time, new applications are being developed.